Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
IBI-3002 in Dermatitis, Atopic: NCT07399067 Clinical Landscape Report 2026
28 September 2026
NCT07399067 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LVIVO-TaVec400 in Relapse multiple myeloma: NCT07399444 Clinical Landscape Report 2026
28 September 2026
NCT07399444 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Semaglutide (Novo Nordisk) in Diabetes Mellitus, Type 2: NCT07401992 Clinical Landscape Report 2026
28 September 2026
NCT07401992 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Apremilast in Arthritis, Psoriatic: NCT07398651 Clinical Landscape Report 2026
28 September 2026
NCT07398651 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tropisetron hydrochloride in Nausea: NCT07413809 Clinical Landscape Report 2026
28 September 2026
NCT07413809 clinical landscape for Nausea: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Gamgertamig in Refractory Multiple Myeloma: NCT07407010 Clinical Landscape Report 2026
28 September 2026
NCT07407010 clinical landscape for Refractory Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
TQH-3906 in Arthritis, Psoriatic: NCT07406035 Clinical Landscape Report 2026
28 September 2026
NCT07406035 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Gamgertamig in Multiple Myeloma: NCT07409454 Clinical Landscape Report 2026
28 September 2026
NCT07409454 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ABBV-438 in Relapse multiple myeloma: NCT07409246 Clinical Landscape Report 2026
28 September 2026
NCT07409246 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SENL-103 in Relapse multiple myeloma: NCT07421856 Clinical Landscape Report 2026
28 September 2026
NCT07421856 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ziftomenib in IDH1 Mutation Acute Myeloid Leukemia: NCT07411586 Clinical Landscape Report 2026
28 September 2026
NCT07411586 clinical landscape for IDH1 Mutation Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Luteolin in Asteatotic eczema: TCTR20260220001 Clinical Landscape Report 2026
28 September 2026
TCTR20260220001 clinical landscape for Asteatotic eczema: endpoints, sponsor, phase, geography, readouts, asset context and development white space.